Get the Stockscreener App
2.05
10.81%
0.20
Biocardia Inc stock is traded at $2.05, with a volume of 44,561.
It is up +10.81% in the last 24 hours and down -23.79% over the past month.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
See More
Previous Close:
$1.85
Open:
$1.85
24h Volume:
44,561
Relative Volume:
0.06
Market Cap:
$7.18M
Revenue:
$468.00K
Net Income/Loss:
$-10.34M
P/E Ratio:
-3.0597
EPS:
-0.67
Net Cash Flow:
$-8.94M
1W Performance:
-10.87%
1M Performance:
-23.79%
6M Performance:
-65.14%
1Y Performance:
-81.04%
1-Day Range:
$1.85
$2.13
1-Week Range:
$1.84
$2.47
52-Week Range:
$1.84
$11.55
Biocardia Inc Stock (BCDA) Company Profile
Name
Biocardia Inc
Sector
Industry
Phone
650-226-0123
Address
320 SOQUEL WAY, SUNNYVALE, CA
Compare BCDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| BCDA | 0.41 | 0 | 0 | 0 | 0 | 0.00 |
| GOODO | 22.16 | 372.90M | 0 | 0 | 0 | 0.00 |
| PSNYW | 0.141 | 297.56M | 2.07B | -1.42B | -1.37B | -0.1344 |
| MOBBW | 0.16 | 278.60M | 0 | 0 | 0 | 0.00 |
| SHMD | 2.61 | 114.98M | 0 | 0 | 0 | 0.00 |
| JUNE | 4.95 | 63.87M | 0 | 0 | 0 | 0.00 |
Biocardia Inc Stock (BCDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-16-21 | Downgrade | Dawson James | Buy → Neutral |
Biocardia Inc Stock (BCDA) Latest News
HC Wainwright Increases Earnings Estimates for BioCardia - Defense World
BioCardia’s (BCDA) “Buy” Rating Reiterated at HC Wainwright - Defense World
BioCardia Third Quarter 2024 Earnings: US$0.61 loss per share (vs US$1.79 loss in 3Q 2023) - Yahoo Finance
BioCardia stock plunges to 52-week low, touches $1.93 - Investing.com India
BioCardia stock plunges to 52-week low, touches $1.93 By Investing.com - Investing.com Nigeria
BioCardia, Inc. (NASDAQ:BCDA) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: BioCardia announces progress in heart therapy trials By Investing.com - Investing.com UK
BioCardia Inc (BCDA) Q3 2024 Earnings Call Highlights: Breakthro - GuruFocus.com
BioCardia Inc (BCDA) Q3 2024 Earnings Call Highlights: Breakthroughs and Challenges in Cardiac ... - Yahoo Finance
BioCardia Reports Q3 2024 Progress and Financials - TipRanks
BioCardia Reports Third Quarter 2024 Business Highlights and Financial Results - The Manila Times
BioCardia Reports 35% Net Loss Improvement, Advances CardiAMP Trial Milestone | BCDA Stock News - StockTitan
BioCardia to Host Q3 2024 Corporate Update and Financial Results Conference Call on November 13, 2024 - The Manila Times
Cell therapy weekly: support for commercialization of complex therapies - RegMedNet
BioCardia concludes pivotal heart failure trial - Investing.com
BioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart Failure - The Manila Times
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.59% - MSN
Beating Heart Patch Market to Make Great Impact in Near Future by 2031 |BIOCARDIA, INC., Athersys, Inc - openPR
BioCardia Inc (BCDA) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - Yahoo Finance
Wall Street SWOT: BioCardia stock rides wave of FDA and CMS support for heart therapy - Investing.com
BioCardia, Inc. (NASDAQ:BCDA) Short Interest Update - Defense World
Trading Day Triumph: Biodesix Inc (BDSX) Ends at 1.59, a -11.67 Surge/Plunge - The Dwinnex
A new trading data show BriaCell Therapeutics Corp (BCTX) is showing positive returns. - SETE News
Dawson James downgrades BioCardia Inc. (BCDA) stock to a Neutral - Knox Daily
Harmony Asset Management LLC Trims Stock Position in The Boeing Company (NYSE:BA) - Defense World
The Boeing Company (NYSE:BA) Shares Sold by Edge Capital Group LLC - Defense World
Beck Capital Management LLC Has $1.47 Million Stock Position in The Boeing Company (NYSE:BA) - Defense World
Summit Trail Advisors LLC Boosts Stock Holdings in The Boeing Company (NYSE:BA) - Defense World
The time has not yet come to remove your chips from the table: Biolife Solutions Inc (BLFS) - SETE News
Sei Investments Co. Acquires 11,092 Shares of The Boeing Company (NYSE:BA) - Defense World
Market Watch Highlights: Biodexa Pharmaceuticals Plc ADR (BDRX) Ends on an Downturn Note at 0.29 - The Dwinnex
Avoro Capital Advisors LLC Has $77.68 Million Stock Holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World
Discovery Capital Management LLC CT Invests $2.47 Million in BioNTech SE (NASDAQ:BNTX) - MarketBeat
Barrow Hanley Mewhinney & Strauss LLC Boosts Position in Bancolombia S.A. (NYSE:CIB) - MarketBeat
Benjamin F. Edwards & Company Inc. Buys 317 Shares of The Boeing Company (NYSE:BA) - Defense World
Benjamin Edwards Inc. Decreases Stake in Bank of America Co. (NYSE:BAC) - MarketBeat
Inspire Investing LLC Reduces Stock Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World
Auxier Asset Management Decreases Stock Position in The Boeing Company (NYSE:BA) - Defense World
Comparing BioLargo (NASDAQ:BLGO) and Chemours (NYSE:CC) - Defense World
Sompo Asset Management Co. Ltd. Has $663,000 Stake in The Boeing Company (NYSE:BA) - Defense World
Benjamin Edwards Inc. Has $816,000 Position in The Boeing Company (NYSE:BA) - Defense World
BioLife Solutions (NASDAQ:BLFS) Trading Up 5.8% - Defense World
Bridges Investment Management Inc. Acquires New Position in Bank of America Co. (NYSE:BAC) - MarketBeat
Is Bank of America Corporation (BAC) the Best Affordable Stock To Buy Right Now? - Yahoo Finance
BANCO DO BRASIL/S (OTCMKTS:BDORY) Share Price Crosses Below 200-Day Moving Average of $5.38 - MarketBeat
Hollencrest Capital Management Boosts Holdings in The Boeing Company (NYSE:BA) - Defense World
Bank of America Corp. stock underperforms Friday when compared to competitors - MarketWatch
IPO News: Everything you need to know about BioAge Labs’ IPO - AlphaStreet
Builders FirstSource (NYSE:BLDR) Given New $198.00 Price Target at Bank of America - Defense World
DCF Advisers LLC Buys 250 Shares of The Boeing Company (NYSE:BA) - Defense World
Acadian Asset Management LLC Sells 107,112 Shares of BioNTech SE (NASDAQ:BNTX) - MarketBeat
Biocardia Inc Stock (BCDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.66%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):